Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mabey

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Vaccine|May 12, 2009
A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in miceJie Wang, Lili Chen, Fan Chen, et al.
Plos Neglected Tropical Diseases|June 17, 2009
When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countriesKathryn J Ray, Thomas M Lietman, Travis C Porco, et al.
Journal of Clinical Microbiology|February 26, 2010
Association of schistosomiasis with false-positive HIV test results in an African adolescent populationDean B Everett, Kathy J Baisely, Ruth McNerney, et al.
Lancet (London, England)|July 1, 2015
Capacity for science in sub-Saharan AfricaAlison Elliott, Barbara Nerima, Bernard Bagaya, et al.
The Journal of Infectious Diseases|September 17, 2002
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomesDeborah Watson-Jones, Balthazar Gumodoka, Helen Weiss, et al.
Microbial Genomics|July 2, 2025
Evolutionary dynamics in the genome of ocular <i>Chlamydia trachomatis</i> strains from Northern Tanzania following mass drug administrationEhsan Ghasemian, Athumani Ramadhani, Anna Harte, et al.
Scientific Reports|April 18, 2023
Population dynamics and drug resistance mutations in Plasmodium falciparum on the Bijagós Archipelago, Guinea-BissauSophie Moss, Emilia Mańko, Hristina Vasileva, et al.
The Lancet. Global Health|August 9, 2014
Sensitivity and specificity of a rapid point-of-care test for active yaws: a comparative studyTelek Ayove, Wendy Houniei, Regina Wangnapi, et al.
The New England Journal of Medicine|February 19, 2015
Mass treatment with single-dose azithromycin for yawsOriol Mitjà, Wendy Houinei, Penias Moses, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or moneyFrances M Cowan, John W Hargrove, Lisa F Langhaug, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Vaccine|May 12, 2009
A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in miceJie Wang, Lili Chen, Fan Chen, et al.
Plos Neglected Tropical Diseases|June 17, 2009
When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countriesKathryn J Ray, Thomas M Lietman, Travis C Porco, et al.
Journal of Clinical Microbiology|February 26, 2010
Association of schistosomiasis with false-positive HIV test results in an African adolescent populationDean B Everett, Kathy J Baisely, Ruth McNerney, et al.
Lancet (London, England)|July 1, 2015
Capacity for science in sub-Saharan AfricaAlison Elliott, Barbara Nerima, Bernard Bagaya, et al.
The Journal of Infectious Diseases|September 17, 2002
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomesDeborah Watson-Jones, Balthazar Gumodoka, Helen Weiss, et al.
Microbial Genomics|July 2, 2025
Evolutionary dynamics in the genome of ocular <i>Chlamydia trachomatis</i> strains from Northern Tanzania following mass drug administrationEhsan Ghasemian, Athumani Ramadhani, Anna Harte, et al.
Scientific Reports|April 18, 2023
Population dynamics and drug resistance mutations in Plasmodium falciparum on the Bijagós Archipelago, Guinea-BissauSophie Moss, Emilia Mańko, Hristina Vasileva, et al.
The Lancet. Global Health|August 9, 2014
Sensitivity and specificity of a rapid point-of-care test for active yaws: a comparative studyTelek Ayove, Wendy Houniei, Regina Wangnapi, et al.
The New England Journal of Medicine|February 19, 2015
Mass treatment with single-dose azithromycin for yawsOriol Mitjà, Wendy Houinei, Penias Moses, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or moneyFrances M Cowan, John W Hargrove, Lisa F Langhaug, et al.
Pageof 17